Cong Chen
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Linbo Wang (15 shared papers)Jichun Zhou (13 shared papers)Yongxia Chen (11 shared papers)Zhaoqing Li (10 shared papers)Lini Chen (6 shared papers)Misha Mao (8 shared papers)Jingjing Yang (5 shared papers)Xun Zhang (6 shared papers)
- Journals
- Biomarker Research (3 papers)Oncotarget (2 papers)Fuel (2 papers)Chinese Journal of Natural Medicines (1 paper)Materials Advances (1 paper)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Cong Chen
53 papers receiving 1.8k citations
Cong Chen's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 449
- Pulmonary and Respiratory Medicine 450
- Geriatrics and Gerontology 40
- Molecular Biology 731
- Oncology 255
Countries citing papers authored by Cong Chen
This map shows the geographic impact of Cong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Chen more than expected).
Fields of papers citing papers by Cong Chen
This network shows the impact of papers produced by Cong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Chen. The network helps show where Cong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer Hit paper breakdown → | 2021 | 285 |
| 2 | Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities Hit paper breakdown → | 2022 | 191 |
| 3 | 2017 | 161 | |
| 4 | 2020 | 155 | |
| 5 | 2022 | 128 | |
| 6 | 2019 | 60 | |
| 7 | 2012 | 60 | |
| 8 | 2014 | 59 | |
| 9 | 2014 | 52 | |
| 10 | 2022 | 48 | |
| 11 | 2014 | 43 | |
| 12 | 2022 | 39 | |
| 13 | 2019 | 31 | |
| 14 | 2021 | 29 | |
| 15 | 2018 | 25 | |
| 16 | 2017 | 24 | |
| 17 | 2022 | 23 | |
| 18 | 2021 | 22 | |
| 19 | 2022 | 22 | |
| 20 | 2022 | 21 |
About Cong Chen
Cong Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Cancer Research, having authored 55 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Sirtuins and Resveratrol in Medicine (4 papers), Tryptophan and brain disorders (4 papers), Breast Cancer Treatment Studies (3 papers), Cancer Cells and Metastasis (3 papers), Energy and Environment Impacts (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (449 citations), Pulmonary and Respiratory Medicine (450 citations), Geriatrics and Gerontology (40 citations), Molecular Biology (731 citations) and Oncology (255 citations). Cong Chen has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Linbo Wang, Jichun Zhou, Yongxia Chen, Zhaoqing Li, Lini Chen, Misha Mao, Jingjing Yang, Xun Zhang, Yulu Zhou and Wenying Zhuo. Their work appears in journals such as Biomarker Research, Oncotarget, Fuel, Chinese Journal of Natural Medicines and Materials Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.